Saturday, August 29th16.8°C
27468
26015

Actavis to buy Forest Labs in $25 billion cash-and-stock drugmaker combination

Actavis PLC plans to buy Forest Laboratories Inc. in an approximately $25 billion deal that will boost the Irish drugmaker's presence in U.S. primary-care doctor offices and bulk up its portfolio of branded drugs.

Actavis will add the Alzheimer's disease treatment Namenda, and newer drugs like the antidepressant Viibryd to its product portfolio with the latest in a string of multi-billion dollar acquisitions that have swelled the drugmaker's size in recent years.

Analyst say the acquisition also gives Actavis more negotiating muscle with hospitals and other care providers that also have grown bigger in recent years.

Actavis said Tuesday it will pay Forest shareholders $26.04 in cash and a portion of an Actavis share for each Forest share. The total, per-share price of $89.48 represents a premium of about 25 per cent over Forest's closing price Friday of $71.39.

Shares of New York-based Forest soared nearly 30 per cent to $92.50 in Tuesday morning trading. That's well above the price Actavis offered, a sign that shareholders believe Forest will receive a better offer. U.S.-traded shares of Dublin-based Actavis climbed 7.6 per cent, or $14.56, to $206.04.

Actavis was formed in 2012 through a $5.6 billion tie-up between generic drugmaker Watson Pharmaceuticals and Actavis Group. It has grown rapidly through acquisitions, including an $8.5 billion deal it closed last fall to buy another Irish drugmaker, Warner Chilcott.

It offers generic drugs and specialty products in areas like urology and women's health. That portfolio includes the osteoporosis treatment Actonel.

New York-based Forest Labs has been squeezed by generic competition to some of its biggest drugs, including its anxiety and depression drug Lexapro. It also faces the loss of patent protection for Namenda in 2015. The company has launched several new drugs, including Viibryd and the lung disease drug Daliresp, to help make up for those losses.

Forest took an annual loss in fiscal 2012, its first in 15 years, and has faced pressure from billionaire investor Carl Icahn, its second-largest shareholder, according to FactSet.

The company has been working to cut costs under new CEO Brent Saunders, who replaced long-standing leader Howard Solomon last fall. The new leader, backed by Icahn, launched plans to cut about 500 jobs as part of a goal to trim $500 million in costs.

Tuesday's announcement comes a few weeks after Forest completed its own acquisition, a $2.9 billion purchase of Aptalis, a company that makes treatments for gastrointestinal problems and cystic fibrosis.

The Canadian Press


Read more Business News

27509


Recent Trending




Today's Market
S&P TSX13865.07+98.40
S&P CDNX555.67+10.10
DJIA16643.01-11.76
Nasdaq4828.32+15.62
S&P 5001988.87+1.21
CDN Dollar0.75730.00
Gold1119.50-5.10
Oil45.26+2.70
Lumber237.20-9.70
Natural Gas2.719+0.055

 
Okanagan Companies
Pacific Safety0.165+0.005
Knighthawk0.010.00
QHR Technologies Inc1.29+0.05
Cantex0.04-0.01
Anavex Life Sciences1.34-0.05
Metalex Ventures0.055+0.000
Russel Metals21.41+0.43
Copper Mountain Mining0.64-0.01
Colorado Resources0.075-0.005
ReliaBrand Inc0.004-0.000
Sunrise Resources Ltd0.025+0.005
Mission Ready Services0.07+0.01
Decisive Dividend Corp2.75+0.14

 



25990

FEATURED Property
2293176#12-880 Christina Place
3 bedrooms 3 baths
$624,900
more details
image2image2image2
Click here to feature your property
Please wait... loading


Agree to ask questions

Photo: Thinkstock.comThe STORY: I think, said Janet to herself, that I just figured out a solution to my problem of letting the prospect run the meeting.With that thought in mind, she got out of her c...


Your business is not a bank

Photo: Thinkstock.comYour plumbing business is not a bank. But when you are giving terms to customers that exceed what you get from your suppliers, you become one. And every time that someone does not...


Begin with the end in mind

Photo: ContributedWe humans love our dates: birthdays, anniversaries, 9/11, the Ides of March - our lives are intimately woven within the tapestry of the calendar. So it should come as no surprise whe...

_





27313


Member of BC Press Council


27438